HES 140 Learning Slides

Embed Size (px)

Citation preview

  • 8/12/2019 HES 140 Learning Slides

    1/12

  • 8/12/2019 HES 140 Learning Slides

    2/12

    Features: Made from Wax Corn Starch MW 130 KD / DS 0.4 exhibits 100% volume effect Volume duration of 4-6 hours

    Indications: Therapy and prophylaxis of

    hypovolemia and shockassociated with surgery, trauma,sepsis and burns

    Dosage: Up to 50 ml/kg/BW/day

    Availability: 500 ml Freeflex Bags in isotonic

    saline solution

  • 8/12/2019 HES 140 Learning Slides

    3/12

    Features: Made from Wax Corn Starch MW 130 KD / DS 0.4 exhibits 100% volume effect Volume duration of 4-6 hours

    Indications: Therapy and prophylaxis of

    hypovolemia and shockassociated with surgery, trauma,sepsis and burns

    Dosage: Up to 50 ml/kg/BW/day

    Availability: 500 ml Freeflex Bags in an

    isotonic electrolyte solution

  • 8/12/2019 HES 140 Learning Slides

    4/12

  • 8/12/2019 HES 140 Learning Slides

    5/12

    6% HES1 3 0 / 0 . 4 / 9 : 1

    Molecular Weight Degree of Substitution Substitution Pattern

  • 8/12/2019 HES 140 Learning Slides

    6/12

    6% Voluven / Volulyte1 3 0 / 0 . 4 / 9 : 1

    Molecular Weight Degree of Substitution Substitution Pattern

    Reduced proportion oflarge, highly substitutedmolecules that may

    cause coagulationdisorders.

    Results in the maintenanceof adequate volume effect &improvement of safety profile

    Known as C2:C6 ratioProvides good duration ofvolume effect

  • 8/12/2019 HES 140 Learning Slides

    7/12

    Waxy Maize Potato Starch

    V RSUS

    95% amylopectin, 5% amylose

    rapidly broken down in the body and

    so could have a longer-lasting volumeeffect vs. potato-based starch (e.g.Tetraspan)

    Low phosphate-ester groups doesntinterfere with blood clottingmechanism, kidney and liver function

    70 -80% amylopectin

    20-30% amylose

    High load of phosphate-ester groups may interfere with blood clottingmechanism, kidney and liver function

    S t r u c t u r a l D i f f e r e n c e s a n dP o s s i b l e o n s e q u e n c e s

    http://www.google.com.ph/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&docid=80gnaPfTOXcbhM&tbnid=jO88HhOWHo686M:&ved=0CAUQjRw&url=http://www.gheg.de/de/products/product/4540_Tetraspan_6_10-Hydroxyethyl_starch_130_0.42/index.html&ei=uU57Uvt9qLWJB9SkgbgC&psig=AFQjCNEYF0tEf-GtGs2SXC_t53m-tG9TPg&ust=1383899106331557
  • 8/12/2019 HES 140 Learning Slides

    8/12

    PLASMA VOLUME EXPANSION EFFEC

    0

    20

    40

    60

    80

    100

    120

    140

    160

    0.5 1 2 3 4 5 6 7 8 Hours after Infusion

    Blood Volume

    (% Infusion)

    Voluven 6% 130/0.4 Crystalloids Gelatins

    Voluven / Volulyte 6% 130 / 0.4provides 100% volume effect for upto 4-6 hours

    Crystalloids 40%, up to 45 minutes.

    Gelatins 70%, up to 2 hours.

    AND VOLUME SUBSTITUTION RATIO

    3 bags; 1 bag

    1;1

    4.7 bags ; 1 bag

    P L A S MA V O L U ME E X PA N S IO N E F F E C T SA N D V O L U M E S U B S T I T U T I O N R AT I O

  • 8/12/2019 HES 140 Learning Slides

    9/12

  • 8/12/2019 HES 140 Learning Slides

    10/12

    LESS RISK OFANAPHYLACTOID

    REACTIONScompared with gelatin anddextransimilar to body glycogen

    NO RELEVANT PLASMA

    ACCUMULATION

    can be safely given to patientsrepeatedly for several dayswithout relevant plasmaaccumulation

    NO CLINICALLY RELEVANTINFLUENCE ON RENALFUNCTION

    Voluven is safe in patientswith all range of renalimpairment as long as urineflow is preserved

    Vo l u v e n &

    Vo l u l y t e

  • 8/12/2019 HES 140 Learning Slides

    11/12

    In summary, with Voluven and Volulyte we achieve a balance between:

  • 8/12/2019 HES 140 Learning Slides

    12/12JLGVTR01202011

    Voluven & Volulyte

    dont accept imitations